Efficacy of radiofrequency ablation of hepatocellular carcinoma prior to liver transplantation and the need for competing-risk analysis

Affiliations

Editorial

Alessandro Cucchetti et al. Hepatobiliary Surg Nutr. 2018 Aug.

. 2018 Aug;7(4):294-296.

doi: 10.21037/hbsn.2018.04.05.

¹ Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum, University of Bologna, Bologna, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW, Raman SS, Asvadi NH, Siripongsakun S, Hicks RM, Chen J, Worakitsitisatorn A, McWilliams J, Tong MJ, Finn RS, Agopian VG, Busuttil RW, Lu DSK. Lee MW, et al. Hepatology. 2017 Jun;65(6):1979-1990. doi: 10.1002/hep.29098. Epub 2017 Apr 28. Hepatology. 2017. PMID: 28170115

1. European Association For The Study Of The Liver. European Organisation For Research And Treatment Of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-43. 10.1016/j.jhep.2011.12.001 - DOI - PubMed
1. Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe. Liver Cancer 2015;4:85-95. 10.1159/000367730 - DOI - PMC - PubMed
1. Cescon M, Cucchetti A, Ravaioli M, et al. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate. J Hepatol 2013;58:609-18. 10.1016/j.jhep.2012.09.021 - DOI - PubMed
1. Lee MW, Raman SS, Asvadi NH, et al. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis. Hepatology 2017;65:1979-90. 10.1002/hep.29098 - DOI - PubMed
1. Cucchetti A, Vitale A, Cescon M, et al. Can liver transplantation provide the statistical cure? Liver Transpl 2014;20:210-7. 10.1002/lt.23783 - DOI - PubMed